# Harrow Health, Inc.: insider transactions

SEC CIK 1360214. Roles and transactions as reported on Form 4. Latest Form 4 filed 2021-04-12.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Eton Pharmaceuticals, Inc.](/companies/eton.md) | 10% owner | 1 | 2021-04-12 | 2021-04-12 |

## Transactions: 1

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2021-04-12 | [Eton Pharmaceuticals, Inc.](/companies/eton.md) | Sale (S) | 1,518,000 | $7.00 | $10.6m | [Form 4](/filings/0001493152-21-008584.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 13:09 ET. No prices; not investment advice.